Cited by 354Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety

Haller, J., Bakos, N., Szirmay, M., Ledent, C., Freund, T. F.·2002·European Journal of Neuroscience

DOI 10.1046/j.1460-9568.2002.02192.x

Open this paper in CoChat — free account

Abstract

The aim of this study was to compare the effects of the genetic and pharmacological disruption of CB1 cannabinoid receptors on the elevated plus‐maze test of anxiety. In the first experiment, the behaviour of CB1‐knockout mice and wild‐type mice was compared. In the second experiment, the cannabinoid antagonist SR141716A (0, 1, and 3 mg/kg) was administered to both CB1‐knockout and wild type mice. Untreated CB1‐knockout mice showed a reduced exploration of the open arms of the plus‐maze apparatus, thus appearing more anxious than the wild‐type animals, however no changes in locomotion were noticed. The vehicle‐injected CB1‐knockout mice from the second experiment also showed increased anxiety as compared with wild types. Surprisingly, the cannabinoid antagonist SR141716A reduced anxiety in both wild type and CB1 knockout mice. Locomotor behaviour was only marginally affected. Recent evidence suggests the existence of a novel cannabinoid receptor in the brain. It has also been shown that SR141716A binds to both the CB1 and the putative novel receptor. The data presented here supports these findings, as the cannabinoid receptor antagonist affected anxiety in both wild type and CB1‐knockout mice. Tentatively, it may be suggested that the discrepancy between the effects of the genetic and pharmacological blockade of the CB1 receptor suggests that the novel receptor plays a role in anxiety.

Integrity signals

Registry

Crossref · 10.1046/j.1460-9568.2002.02192.x

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628
Self-citation
A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety
Hogg, S. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02126-4 · Cited by 1,169
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,078
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. M., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, É., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 597
Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
Breivogel, C. S., Griffin, G., Marzo, V. D., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 538
Involvement of CB1 cannabinoid receptors in emotional behaviour
Martín, M., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0946-5 · Cited by 525
Self-citation
Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus
Hájos, N., Ledent, C. A., & Freund, T. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00287-1 · Cited by 421
Self-citation
Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice
Marzo, V. D., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 394
In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.
Compton, D. M., Aceto, M. D. G., Lowe, J. A., III, & Martin, B. R. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12911-x · Cited by 357
Pharmacological characterization of cannabinoids in the elevated plus maze.
Onaivi, E. S., Green, M. R., & Martin, B. R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13195-9 · Cited by 312

Show all 26 references

Sorted by citations

Items 101–200 of 354

ROLE OF DORSAL HIPPOCAMPAL CANNABINOID RECEPTORS AND NITRIC OXIDE IN ANXIETY LIKE BEHAVIOURS IN RATS USING THE ELEVATED PLUS‐MAZE TEST
Roohbakhsh, A., Moghaddam, A. H., Massoudi, R., & Zarrindast, M. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04576.x · Cited by 82
CB1 Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action
Degroot, A., Köfalvi, A., Wade, M. R., Davis, R. J., Rodrigues, R. J., Rebola, N., Cunha, R. A., & Nomikos, G. G. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024661 · Cited by 82
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
Tsetsenis, T., Younts, T. J., Chiu, C. Q., Kaeser, P. S., Castillo, P. E., & Südhof, T. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112237108 · Cited by 81
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects
Monteleone, P., Bifulco, M., Filippo, C. D., Gazzerro, P., Canestrelli, B., Monteleone, F., Proto, M., Genio, M. D., Grimaldi, C., & Maj, M. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00518.x · Cited by 81
The cannabinoid CB 1 receptor and the endocannabinoid anandamide: possible antidepressant targets
Bambico, F. R., & Gobbi, G. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.11.1347 · Cited by 80
Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
Hillard, C. J., & Liu, Q.-S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660735 · Cited by 82
Endocannabinoids Mediate the Effects of Acute Stress and Corticosterone on Sex Behavior
Coddington, E. J., Lewis, C. M., Rose, J. D., & Moore, F. L. (2006) · Endocrinology · doi:10.1210/en.2006-0740 · Cited by 78
Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder
Neumeister, A., Seidel, J., Ragen, B., & Pietrzak, R. H. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.012 · Cited by 76
Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5‐HTTLPR affect the anxious phenotype
Lazáry, J., Lazáry, Á., Gonda, X., Benkő, A., Molnár, E., Hunyady, L., Juhász, G., & Bagdy, G. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31024 · Cited by 75
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice
Cassano, T., Gaetani, S., Macheda, T., Laconca, L., Romano, A., Morgese, M. G., Cimmino, C. S., Chiarotti, F., Bambico, F. R., Gobbi, G., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2051-0 · Cited by 72
Endocannabinoid modulation of fear responses: learning and state-dependent performance effects
Reich, C. G., Mohammadi, M., & Alger, B. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107083999 · Cited by 72
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression
Mangieri, R. A., & Piomelli, D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.003 · Cited by 73
CB1 cannabinoid receptor-mediated aggressive behavior
Rodríguez‐Arias, M., Navarrete, F., Daza‐Losada, M., Navarro, D., Aguilar, M. A., Berbel, P. J., Miñarro, J., & Manzanares, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.013 · Cited by 72
Modulation of Fear and Anxiety by the Endogenous Cannabinoid System
Chhatwal, J. P., & Ressler, K. J. (2007) · CNS Spectrums · doi:10.1017/s1092852900020939 · Cited by 71
Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance
Trezza, V., Campolongo, P., Manduca, A., Morena, M., Palmery, M., Vanderschuren, L. J. M. J., & Cuomo, V. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00002 · Cited by 69
Endocannabinoids and Mental Disorders
Rubino, T., Zamberletti, E., & Parolaro, D. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_9 · Cited by 72
Cognitive enhancers for anxiety disorders
Hofmann, S. G., Smits, J. A. J., Asnaani, A., Gutner, C. A., & Otto, M. W. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.020 · Cited by 69
Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
Hasbi, A., Madras, B. K., & George, S. R. (2023) · Brain Sciences · doi:10.3390/brainsci13020325 · Cited by 69
Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimer's Disease
Bedse, G., Romano, A., Cianci, S., Lavecchia, A. M., Pace, L., Elphick, M. R., LaFerla, F. M., Vendemiale, G., Grillo, C., Fabio Altieri, F., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131910 · Cited by 69
Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system
Zarrindast, M., Sarahroodi, S., Arzi, A., Khodayar, M. J., Shalmani, S. T., & Rezayof, A. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283123c83 · Cited by 68
Altered CB1receptor‐signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine
Rodríguez‐Gaztelumendi, A., Rojo, M. L., Pazos, Á., & Díaz, Á. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05898.x · Cited by 68
Developmental regulation of fear learning and anxiety behavior by endocannabinoids
Lee, T. T.-Y., Hill, M. N., & Lee, F. S. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12253 · Cited by 71
Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents
Wade, M. R., Degroot, A., & Nomikos, G. G. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.083 · Cited by 67
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability
Schurman, L. D., Wills, K. L., Segsworth, B. M., Dashney, B., Rock, E. M., Limebeer, C. L., & Parker, L. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.10.008 · Cited by 66
Effects of cannabinoids on the anxiety-like response in mice.
Rutkowska, M., Jamontt, J., & Gliniak, H. (2006) · PubMed · Cited by 66
The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives
Marco, E. M., & Laviola, G. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408459 · Cited by 67
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1−/− mice
Bilkei‐Gorzó, A., Drews, E., Albayram, Ö., Piyanova, A., Gaffal, E., Tueting, T., Michel, K., Mauer, D., Maier, W., & Zimmer, A. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.009 · Cited by 64
Cocaine- and amphetamine related transcript (CART) and anxiety
Stanek, L. M. (2006) · Peptides · doi:10.1016/j.peptides.2006.01.027 · Cited by 64
CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat
Vlachou, S., Nomikos, G. G., & Panagis, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2050-0 · Cited by 64
CB 1receptor antagonists: new discoveries leading to new perspectives
Kirilly, E., Gonda, X., & Bagdy, G. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2012.02402.x · Cited by 80
Analysis of the Endocannabinoid System by Using CB1 Cannabinoid Receptor Knockout Mice
Valverde, O., Karsak, M., & Zimmer, A. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_4 · Cited by 61
The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice
Mikics, É., Dombi, T., Barsvári, B., Varga, B., Ledent, C., Freund, T., & Haller, J. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200605000-00003 · Cited by 61
Self-citation
Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses
Maldonado, R. J., & Valverde, O. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.001 · Cited by 62
Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?
Moreira, F. A., de Aguiar, D. C., Campos, A. C., Lisboa, S. F. D. S., Terzian, A. L. B., Resstel, L. B. M., & Guimarães, F. S. (2008) · Neural Plasticity · doi:10.1155/2009/625469 · Cited by 62
Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock‐probe burying test
Degroot, A., & Nomikos, G. G. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03556.x · Cited by 58
Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects
Rahn, E. J., Thakur, G. A., Wood, J. A. T., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.024 · Cited by 57
FMR1 and Autism, an Intriguing Connection Revisited
Fyke, W., & Velinov, M. T. (2021) · Genes · doi:10.3390/genes12081218 · Cited by 60
Localization and Function of the Cannabinoid CB1 Receptor in the Anterolateral Bed Nucleus of the Stria Terminalis
Puente, N., Elezgarai, I., Lafourcade, M., Reguero, L., Marsicano, G., Georges, F. E., Manzoni, O. J., & Grandes, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008869 · Cited by 63
Effects of Δ9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress
Fokos, S., & Panagis, G. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109104904 · Cited by 57
Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study
Rabinak, C. A., Blanchette, A., Zabik, N. L., Peters, C., Marusak, H. A., Iadipaolo, A. S., & Elrahal, F. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05499-8 · Cited by 57
Context-Specific Reversal of Cocaine Sensitization by the CB1 Cannabinoid Receptor Antagonist Rimonabant
Gerdeman, G. L., Schechter, J. B., & French, E. D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301648 · Cited by 56
An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters
Moise, A. M., Eisenstein, S. A., Astarita, G., Piomelli, D., & Hohmann, A. G. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1209-5 · Cited by 55
The Endocannabinoid System and Anxiety
Lisboa, S. F. D. S., Gomes, F. V., Terzian, A. L. B., de Aguiar, D. C., Moreira, F. A., Resstel, L. B. M., & Guimarães, F. S. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.006 · Cited by 56
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress
Bedse, G., Colangeli, R., Lavecchia, A. M., Romano, A., Fabio Altieri, F., Cifani, C., Cassano, T., & Gaetani, S. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.07.005 · Cited by 52
Endocannabinoid System and TRPV1 Receptors in the Dorsal Hippocampus of the Rats Modulate Anxiety-like Behaviors.
Hakimizadeh, E., Oryan, S., Moghaddam, A. H., Shamsizadeh, A., & Roohbakhsh, A. (2012) · Europe PMC (PubMed Central) · Cited by 53
The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization
Thiemann, G., VANDERSTELT, M., Petrosino, S., Molleman, A., Marzo, V. D., & Hasenöhrl, R. U. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.09.022 · Cited by 51
Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral‐Antagonist/Inverse‐Agonist Therapies
Ward, S. J., & Raffa, R. B. (2011) · Obesity · doi:10.1038/oby.2011.69 · Cited by 50
Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy
Voicu, V. A., Brehar, F.-M., Toader, C., Covache-Busuioc, R.-A., Corlatescu, A.-D., Bordeianu, A., Costin, H. P., Bratu, B.-G., Glavan, L.-A., & Ciurea, A. V. (2023) · Biomolecules · doi:10.3390/biom13091388 · Cited by 52
Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice
Chegini, H., Nasehi, M., & Zarrindast, M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.12.007 · Cited by 52
Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing
Horder, J., Browning, M., Di Simplicio, M., Cowen, P. J., & Harmer, C. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111400649 · Cited by 48
AAV-Mediated Overexpression of the CB1 Receptor in the mPFC of Adult Rats Alters Cognitive Flexibility, Social Behavior, and Emotional Reactivity
Klugmann, M., Goepfrich, A., Friemel, C. M., & Schneider, M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00037 · Cited by 49
Role of endocannabinoid system in mental diseases
Manzanares, J., Urigüen, L., Rubio, G., & Palomo, T. (2004) · Neurotoxicity Research · doi:10.1007/bf03033223 · Cited by 49
Cannabis and endocannabinoid modulators: Therapeutic promises and challenges
Grant, I., & Cahn, B. R. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.015 · Cited by 51
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Austrich-Olivares, A., García‐Gutiérrez, M. S., Illescas, L., Gasparyan, A., & Manzanares, J. (2022) · Pharmaceuticals · doi:10.3390/ph15040473 · Cited by 52
CB1Cannabinoid Receptor Modulates 3,4-Methylenedioxymethamphetamine Acute Responses and Reinforcement
Touriño, C., Ledent, C. A., Maldonado, R. J., & Valverde, O. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.003 · Cited by 46
Self-citation
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
Rodrigues, R. S., Lourenço, D. M., Paulo, S. L., Mateus, J. M., Ferreira, M. F., Mouro, F. M., Moreira, J. B., Ribeiro, F. F., Sebastião, A. M., & Xapelli, S. (2019) · Molecules · doi:10.3390/molecules24071350 · Cited by 47
Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716
Singh, M. E., Verty, A. N. A., Price, I., McGregor, I. S., & Mallet, P. E. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.008 · Cited by 45
Involvement of the GABAergic system in PTSD and its therapeutic significance
Huang, J., Xu, F., Yang, L.-P., Tuolihong, L., Wang, X., Du, Z., Zhang, Y., Yin, X., Li, Y.-J. D., Lu, K., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1052288 · Cited by 41
A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy
Eisenstein, S. A., Clapper, J. R., Holmes, P. V., Piomelli, D., & Hohmann, A. G. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.12.013 · Cited by 45
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia
Arnold, J. C., Boucher, A. A., & Karl, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884726 · Cited by 45
The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions
Viveros, M., Marco, E. M., Llorente, R., & Lamota, L. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d28fb4 · Cited by 44
Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain
Thiemann, G., Watt, C. A., Ledent, C. A., Molleman, A., & Hasenöhrl, R. U. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.035 · Cited by 44
Self-citation
CB1 receptors modulate affective behaviour induced by neuropathic pain
Rácz, I., Nent, E., Erxlebe, E., & Zimmer, A. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.03.005 · Cited by 43
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention
Zer‐Aviv, T. M., Segev, A., & Akirav, I. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000253 · Cited by 43
Social isolation as a promising animal model of PTSD comorbid suicide: neurosteroids and cannabinoids as possible treatment options
Locci, A., & Pinna, G. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.12.014 · Cited by 42
Communication and social interaction in the cannabinoid‐type 1 receptor null mouse: Implications for autism spectrum disorder
Fyke, W., Premoli, M., Echeverry‐Alzate, V., López‐Moreno, J. A., Lemaire, V., Crusio, W. E., Marsicano, G., Wöhr, M., & Pietropaolo, S. (2021) · Autism Research · doi:10.1002/aur.2562 · Cited by 43
Role of CB2 receptors in social and aggressive behavior in male mice
Rodríguez‐Arias, M., Navarrete, F., Blanco-Gandía, M. C., Arenas, M. C., Aguilar, M. A., Bartoll-Andrés, A., Valverde, O., Miñarro, J., & Manzanares, J. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3939-5 · Cited by 41
Detection of cannabinoid agonist evoked increase in BOLD contrast in rats using functional magnetic resonance imaging
Shah, Y. B., Prior, M. J. W., Dixon, A. L., Morris, P. G., & Marsden, C. A. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.023 · Cited by 41
Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice
Bowers, M. E., & Ressler, K. J. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.005 · Cited by 40
Endocannabinoid Regulation of Neuroendocrine Systems
Tasker, J. G., Chen, C., Fisher, M. O., Fu, X., Rainville, J. R., & Weiss, G. L. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.09.003 · Cited by 41
Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission
Mikics, É., Vas, J., Aliczki, M., Halász, J., & Haller, J. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832c70b1 · Cited by 39
Self-citation
CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats
Rubio, M., Fernández‐Ruíz, J., de Miguel, R., Maestro, B., Walker, J. M., & Ramos, J. A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.02.005 · Cited by 39
Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice
Gamble‐George, J., Conger, J. R., Hartley, N. D., Gupta, P., Sumislawski, J. J., & Patel, S. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3042-8 · Cited by 41
Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia
Haller, J., Szirmai, M., Varga, B., Ledent, C. A., & Freund, T. F. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00014 · Cited by 39
Self-citation
Role of Endocannabinoid System in the Ventral Hippocampus of Rats in the Modulation of Anxiety‐Like Behaviours
Roohbakhsh, A., Keshavarz, S., Hasanein, P., Rezvani, M. E., & Moghaddam, A. H. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00449.x · Cited by 39
Endocannabinoid lipids and mediated system: Implications for alcoholism and neuropsychiatric disorders
Vinod, K. Y., & Hungund, B. L. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.041 · Cited by 38
Steroidogenic Factor 1 Regulates Expression of the Cannabinoid Receptor 1 in the Ventromedial Hypothalamic Nucleus
Kim, K. W., Jo, Y., Zhao, L., Stallings, N. R., Chua, S. C., & Parker, K. L. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0127 · Cited by 38
Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders
Vinod, K. Y., & Hungund, B. L. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.2.203 · Cited by 38
Anxiety-like behavior induced by histaminergic agents can be prevented by cannabinoidergic WIN55,212-2 injected into the dorsal hippocampus in mice
Zarrindast, M., Nasehi, M. M., Piri, M., & Bina, P. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.09.021 · Cited by 37
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies
Xing, G., Carlton, J. R., Jiang, X., Wen, J., Jia, M., & Li, H. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00161 · Cited by 39
Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice
Manzanedo, C., Rodríguez‐Arias, M., Daza‐Losada, M., Maldonado, C., Aguilar, M. A., & Miñarro, J. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-19 · Cited by 36
Behavioral effects of the novel cannabinoid full agonist AM 411
McLaughlin, P. J., Lü, D., Winston, K. M., THAKUR, G., Swezey, L. A., Makriyannis, A., & Salamone, J. D. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.02.005 · Cited by 36
Blocking the Cannabinoid Receptors: Drug Candidates and Therapeutic Promises
Muccioli, G. G. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790153 · Cited by 36
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB1 receptor antagonists
Kirilly, E., Hunyady, L., & Bagdy, G. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0900-1 · Cited by 34
Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure
Reyes, B. A. S., Szot, P., Sikkema, C. L., Cathel, A. M., Kirby, L. G., & Bockstaele, E. J. V. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.016 · Cited by 35
Antidepressant-induced undesirable weight gain: Prevention with rimonabant without interference with behavioral effectiveness
Gobshtis, N., Ben‐Shabat, S., & Fride, E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.028 · Cited by 34
Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse
Xing, G., Carlton, J. R., Zhang, L., Jiang, X., Fullerton, C. S., Li, H., & Ursano, R. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.013 · Cited by 35
Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington's disease
Pietropaolo, S., Bellocchio, L., Ruiz-Calvo, A., Cabanas, M., Du, Z., Guzmán, M., Garret, M., & Cho, Y. H. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.07.021 · Cited by 34
Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders
Estrada, J. A., & Contreras, I. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200217140255 · Cited by 33
Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice
Aracil-Fernández, A., Almela, P., & Manzanares, J. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00406.x · Cited by 31
Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task
Wise, L. E., Harloe, J. P., & Lichtman, A. H. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.06.001 · Cited by 31
Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze
Gobira, P. H., de Aguiar, D. C., & Moreira, F. A. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.013 · Cited by 28
Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase
Vecchiarelli, H. A., Morena, M., Keenan, C. M., Chiang, V., Tan, K., Qiao, M., Leitl, K. D., Santori, A., Pittman, Q. J., Sharkey, K. A., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00939-7 · Cited by 29
The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines
García‐Gutiérrez, M. S., & Manzanares, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109106910 · Cited by 30
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders
Janssen, F. J., & van der Stelt, M. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.06.076 · Cited by 27
Genetic Manipulation of the Endocannabinoid System
Zimmer, A. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_5 · Cited by 26
A review of the effects of acute and chronic cannabinoid exposure on the stress response
Glodosky, N. C., Cuttler, C., & McLaughlin, R. J. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100945 · Cited by 31
Disruption of peri-adolescent endocannabinoid signaling modulates adult neuroendocrine and behavioral responses to stress in male rats
Lee, T. T.-Y., Hill, M. N., Hillard, C. J., & Gorzalka, B. B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.021 · Cited by 26
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors
Nader, J., Rapino, C., Gennequin, B., Chavant, F., Francheteau, M., Makriyannis, A., Duranti, A., Maccarrone, M., Solinas, M., & Thiriet, N. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.03.014 · Cited by 27
The Anxiolytic Potential and Psychotropic Side Effects of an Echinacea Preparation in Laboratory Animals and Healthy Volunteers
Haller, J., Freund, T. F., Gyimesi-Pelczer, K., Füredi, J., Krecsák, L., & Zámbori, J. (2012) · Phytotherapy Research · doi:10.1002/ptr.4677 · Cited by 26
Self-citation

Authors: Haller, J., Bakos, N., Szirmay, M., Ledent, C., & Freund, T. F.
Affiliations: HUN-REN Institute of Experimental Medicine (HU)
Université Libre de Bruxelles (BE)
Corresponding author: Freund, T. F.
ORCID: Haller, J.
Ledent, C.
Venue: European Journal of Neuroscience
Publisher: Wiley
Published: 2002-10
Volume: 16
Issue: 7
Pages: 1395-1398
ISSN: 0953-816X (ISSN-L)
1460-9568
DOI: 10.1046/j.1460-9568.2002.02192.x
OpenAlex: W2027352187
Cited by: 354
References: 26
Citations by year: 2026: 5 · 2025: 10 · 2024: 5 · 2023: 14 · 2022: 6 · 2021: 14 · 2020: 9 · 2019: 8 · 2018: 11 · 2017: 13 · 2016: 11 · 2015: 16 · 2014: 16 · 2013: 18 · 2012: 18
FWCI: 9.01
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 28 d)
Locations: European Journal of Neuroscience (publishedVersion)
PubMed (publishedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
Funders: Hungarian Scientific Research Fund
National Institute of Mental Health (R01MH054671, MH54671)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: CB1 receptor, anxiety, CB1 knockout mice, SR141716A, cannabinoid receptor antagonists, elevated plus maze, locomotor behaviour
MeSH terms: Rimonabant, Animals, Anxiety, Exploratory Behavior, Motor Activity, Piperidines, Pyrazoles, Receptors, Drug, Mice, Knockout, Maze Learning, Receptors, Cannabinoid, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks